𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of Clinical Outcomes of Overlapping Sirolimus- Versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

✍ Scribed by William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C. Clavijo; William O. Suddath; Augusto D. Pichard; Lowell F. Satler; Kenneth M. Kent; Ron Waksman

Book ID
113443345
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
117 KB
Volume
98
Category
Article
ISSN
0002-9149

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of three or more sirolimus-elutin
Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention
✍ William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## Objectives: The purpose of this study was to examine the clinical outcomes of patients who underwent stenting with β‰₯3 sirolimus‐eluting stents (SES) when compared with those treated with β‰₯3 paclitaxel‐eluting stents (PES). ## Background: Drug‐eluting stent (DES) implantation for s

Impact of overlapping drug-eluting stent
Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention
✍ William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

## Abstract Background: Sirolimus‐eluting stent (SES) implantation for the treatment of single coronary lesions is proven to be effective and durable. However, the safety and efficacy of overlapping SES for the treatment of long lesions have not been well established. Objectives: We conducted a ret